Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases

Details for Australian Patent Application No. 2004281959 (hide)

Owner IMTM GmbH KeyNeurotek Pharmaceuticals AG

Inventors Tager, Michael; Bank, Ute; Striggow, Frank; Nordhoff, Karsten; Ansorge, Siegfried

Agent Cullen & Co

Pub. Number AU-B-2004281959

PCT Pub. Number WO2005/037779

Priority 103 48 022.6 15.10.03 DE

Filing date 15 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 23 July 2009

International Classifications

C07D 205/08 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

C07C 229/34 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07C 235/56 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 243/28 (2006.01) Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes

C07C 251/80 (2006.01) Compounds containing nitrogen atoms doubly- bound to a carbon skeleton

C07C 251/86 (2006.01) Compounds containing nitrogen atoms doubly- bound to a carbon skeleton

C07C 255/61 (2006.01) Carboxylic acid nitriles

C07C 259/14 (2006.01) Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups

C07C 271/28 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07C 311/08 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/19 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/29 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 323/60 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07C 327/48 (2006.01) Thiocarboxylic acids

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 225/02 (2006.01) Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07F 9/6506 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/037779 Priority application(s): WO2005/037779

17 April 2008 Alteration of Name

  The name of the applicant has been altered to IMTM GmbH; KeyNeurotek Pharmaceuticals AG

23 July 2009 Application Accepted

  Published as AU-B-2004281959

19 November 2009 Standard Patent Sealed

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281960-Sulfoximine-substituted pyrimidines for use as CDK and/or VEGF inhibitors, the production thereof and their use as drugs

2004281952-C10 alkanolalkoxylate mixtures and use thereof as novel low-foaming wetting agents